Cystic Diseases of the Kidney
Cystic diseases of the kidney (CKD) are fairly rare compared with other types of kidney conditions. We offer FDA-approved therapies for CKD. Vanderbilt nephrologists were lead researchers and clinicians in the development of these medications. We continue to work for improved treatments for people affected by these diseases.
Conditions We Treat
We treat all cystic kidney diseases and related conditions, including:
- Angiomyolipoma (AML) of the kidney
- Autosomal dominant polycystic kidney disease
- Autosomal recessive polycystic kidney disease
- Kidney cysts associated with tuberous sclerosis complex (TSC) or lymphangioleiomyomatosis (LAM)
Meet Your Care Team
Why Choose Cystic Diseases of the Kidney at Vanderbilt
- Advanced research
Vanderbilt researchers helped conduct the research that led to FDA approval for tolvaptan to treat polycystic kidney disease. This is the first medical therapy approved to treat PKD.
- Team approach
Our doctors work with experts in radiology, neurology, urology and pulmonology (lung care) to offer comprehensive care for your needs. Together we study your symptoms, medical history and treatment options. You receive advice and care shaped by a team of experts.
- Advanced treatment
Kidney specialists at Vanderbilt are some of the only experts in Tennessee who treat with everolimus (marketed under the brand name Afinitor), an FDA-approved medication for angiomyolipomas.
- Second opinions
A second opinion can help you make the best decisions. We review your medical history, diagnostic tests, any previous treatments and your personal preferences to provide you with an informed opinion.